Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs

被引:180
作者
Ramsay, Rona R. [1 ]
Tipton, Keith F. [2 ]
机构
[1] Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 8QP, Fife, Scotland
[2] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland
关键词
Alzheimer's disease; l-deprenyl (selegiline); donepezil; galantamine; inhibitor constant; enzyme inhibition; multitarget-directed ligand (MTDL); rasagiline; rivastigmine; ACTIVATED IRREVERSIBLE INHIBITION; BUTYRYLCHOLINESTERASE K VARIANT; CONTAINING AMINE OXIDASES; PERIPHERAL ANIONIC SITE; MAO-A; ACETYLCHOLINESTERASE ACTIVITY; ALZHEIMERS-DISEASE; L-DEPRENYL; SPECTROPHOTOMETRIC ASSAY; REVERSIBLE INHIBITION;
D O I
10.3390/molecules22071192
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The actions of many drugs involve enzyme inhibition. This is exemplified by the inhibitors of monoamine oxidases (MAO) and the cholinsterases (ChE) that have been used for several pharmacological purposes. This review describes key principles and approaches for the reliable determination of enzyme activities and inhibition as well as some of the methods that are in current use for such studies with these two enzymes. Their applicability and potential pitfalls arising from their inappropriate use are discussed. Since inhibitor potency is frequently assessed in terms of the quantity necessary to give 50% inhibition (the IC50 value), the relationships between this and the mode of inhibition is also considered, in terms of the misleading information that it may provide. Incorporation of more than one functionality into the same molecule to give a multi-target-directed ligands (MTDLs) requires careful assessment to ensure that the specific target effects are not significantly altered and that the kinetic behavior remains as favourable with the MTDL as it does with the individual components. Such factors will be considered in terms of recently developed MTDLs that combine MAO and ChE inhibitory functions.
引用
收藏
页数:46
相关论文
共 238 条
[1]   Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): Comparisons with human MAO A and MAO B [J].
Aldeco, Milagros ;
Arslan, Betuel Kacar ;
Edmondson, Dale E. .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 2011, 159 (02) :78-83
[3]   A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease [J].
Anand, Preet ;
Singh, Baldev ;
Singh, Nirmal .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (03) :1175-1180
[4]   MONOAMINE-OXIDASE INHIBITORS AND THE CHEESE EFFECT [J].
ANDERSON, MC ;
HASAN, F ;
MCCRODDEN, JM ;
TIPTON, KF .
NEUROCHEMICAL RESEARCH, 1993, 18 (11) :1145-1149
[5]  
[Anonymous], 2002, ENZYME ASSAYS PRACTI
[6]   CHANGES IN ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE IN ALZHEIMERS-DISEASE RESEMBLE EMBRYONIC-DEVELOPMENT - A STUDY OF MOLECULAR-FORMS [J].
ARENDT, T ;
BRUCKNER, MK ;
LANGE, M ;
BIGL, V .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (03) :381-396
[7]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[8]   Free energy landscape for the binding process of Huperzine A to acetylcholinesterase [J].
Bai, Fang ;
Xu, Yechun ;
Chen, Jing ;
Liu, Qiufeng ;
Gu, Junfeng ;
Wang, Xicheng ;
Ma, Jianpeng ;
Li, Honglin ;
Onuchic, Jose N. ;
Jiang, Hualiang .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (11) :4273-4278
[9]   Metabolism of monoamine oxidase inhibitors [J].
Baker, GB ;
Urichuk, LJ ;
McKenna, KF ;
Kennedy, SH .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1999, 19 (03) :411-426
[10]  
Ballard Clive G., 2005, Current Alzheimer Research, V2, P307